Target intelligence / Profile preview

Orbital inflammatory cells

Molecular classification
Immune cells, Cellular infiltration, Macrophages, T cells, B cells
01

Overview

Inflammatory cells in orbital tissue refer to a collection of immune cells that infiltrate the orbital fat compartment and surrounding structures during inflammatory orbital diseases. These cells play an active role in the pathogenesis of various orbital inflammatory conditions. They include various immune cell types such as macrophages, T cells, B cells, and other inflammatory cells that diffusely infiltrate the orbital fat compartment. They are responsible for producing and releasing various pro-inflammatory mediators including pro-inflammatory cytokines (IL-6, TNF-α, IL-1β, IL-17A, IL-2, IL-8, IL-10, IL-12, and gamma interferon), fibrogenic growth factors, oxygen-free radicals, and glycosaminoglycans. These mediators act on orbital fat and surrounding tissues, stimulating various pathological processes including adipogenesis, fibroblast proliferation, and expression of immunomodulatory molecules.

Other names
Inflammatory cells in orbital tissueImmune cells in orbital tissue
02

Mechanism of action

Drugs targeting these cells or their mediators work by suppressing the immune response and inflammation, thereby reducing cellular infiltration and the production of pro-inflammatory mediators.

03

Biological functions

Mediate inflammatory reactions in orbital tissuesContribute to the expansion of orbital fat and fibrosis of extraocular muscles (tissue remodeling)Release pro-inflammatory cytokines that perpetuate inflammation (cytokine production)Stimulate the production of glycosaminoglycans that accumulate in orbital tissues (glycosaminoglycan synthesis)
04

Disease associations

Play significant roles in various orbital inflammatory conditionsGraves' orbitopathy/ophthalmopathy (circulating lymphocytes infiltrate orbital soft tissues)Nonspecific orbital inflammation (orbital pseudotumor)Sarcoidosis (granulomatous inflammation in orbital tissues)IgG4-related disease (IgG4-positive plasma cell infiltration)
05

Safety considerations

Not explicitly detailed in the provided text.Steroid resistance may lead to the need for alternative immunosuppressive agents.
06

Interacting drugs

Corticosteroids

2 more in the full profile.

07

Biomarkers

Elevated pro-inflammatory cytokines (e.g., IL-6, TNF-α, IL-1β, IL-17A, IL-2, IL-8, IL-10, IL-12, gamma interferon)

Beyond the preview

Go deeper on Orbital inflammatory cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orbital inflammatory cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call